177. Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension
Titel:
177. Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension
Auteur:
Bar-Or, Amit Oh, Jiwon Dufek, Michal Budincevic, Hrvoje Habek, Mario Caunt, Maresa Thomas, Piia Sierzega, Malgorzata Clayton, David Chen, Ying-Fang Ratchford, John N. Goodyear, Alexandra Drulovic, Jelena